405 related articles for article (PubMed ID: 17548806)
21. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.
Loiarro M; Gallo G; Fantò N; De Santis R; Carminati P; Ruggiero V; Sette C
J Biol Chem; 2009 Oct; 284(41):28093-28103. PubMed ID: 19679662
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
Youn HS; Saitoh SI; Miyake K; Hwang DH
Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
[TBL] [Abstract][Full Text] [Related]
23. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-{kappa}B.
Loiarro M; Sette C; Gallo G; Ciacci A; Fantò N; Mastroianni D; Carminati P; Ruggiero V
J Biol Chem; 2005 Apr; 280(16):15809-14. PubMed ID: 15755740
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1-receptor-associated kinase 2 (IRAK2)-mediated interleukin-1-dependent nuclear factor kappaB transactivation in Saos2 cells requires the Akt/protein kinase B kinase.
Cenni V; Sirri A; De Pol A; Maraldi NM; Marmiroli S
Biochem J; 2003 Nov; 376(Pt 1):303-11. PubMed ID: 12906710
[TBL] [Abstract][Full Text] [Related]
25. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles.
Hirayama T; Tamaki Y; Takakubo Y; Iwazaki K; Sasaki K; Ogino T; Goodman SB; Konttinen YT; Takagi M
J Orthop Res; 2011 Jul; 29(7):984-92. PubMed ID: 21308757
[TBL] [Abstract][Full Text] [Related]
26. Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats.
Wang N; Han X; Liu H; Zhao T; Li J; Feng Y; Mi X; Zhang Y; Chen Y; Wang X
Exp Neurol; 2017 Sep; 295():23-35. PubMed ID: 28529112
[TBL] [Abstract][Full Text] [Related]
27. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
[TBL] [Abstract][Full Text] [Related]
28. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3.
Huang Q; Yang J; Lin Y; Walker C; Cheng J; Liu ZG; Su B
Nat Immunol; 2004 Jan; 5(1):98-103. PubMed ID: 14661019
[TBL] [Abstract][Full Text] [Related]
29. Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.
He WT; Zhang LM; Li C; Li SY; Ding ZC; Fang ZM; Meng FY; Chen ZK; Zhou P
Transpl Int; 2016 Aug; 29(8):941-52. PubMed ID: 27125343
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
31. MyD88-induced downregulation of IRAK-4 and its structural requirements.
Hatao F; Yamamoto M; Muroi M; Kaminishi M; Tanamoto K
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):260-4. PubMed ID: 18503546
[TBL] [Abstract][Full Text] [Related]
32. IL-1R-associated kinase-1 mediates protein kinase Cδ-induced IL-1β production in monocytes.
Tiwari RL; Singh V; Singh A; Barthwal MK
J Immunol; 2011 Sep; 187(5):2632-45. PubMed ID: 21804018
[TBL] [Abstract][Full Text] [Related]
33. FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction.
Zhande R; Dauphinee SM; Thomas JA; Yamamoto M; Akira S; Karsan A
Mol Cell Biol; 2007 Nov; 27(21):7394-404. PubMed ID: 17785432
[TBL] [Abstract][Full Text] [Related]
34. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
Akira S; Hoshino K
J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
[TBL] [Abstract][Full Text] [Related]
35. Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types.
Chiang EY; Yu X; Grogan JL
J Immunol; 2011 Jan; 186(2):1279-88. PubMed ID: 21160042
[TBL] [Abstract][Full Text] [Related]
36. A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses.
Bartfai T; Behrens MM; Gaidarova S; Pemberton J; Shivanyuk A; Rebek J
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7971-6. PubMed ID: 12799462
[TBL] [Abstract][Full Text] [Related]
37. CpG oligonucleotides induce an immune response of odontoblasts through the TLR9, MyD88 and NF-kappaB pathways.
He W; Yu Q; Zhou Z; Wang P
Biochem Biophys Res Commun; 2010 Aug; 399(2):274-8. PubMed ID: 20655295
[TBL] [Abstract][Full Text] [Related]
38. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.
Yamamoto T; Tsutsumi N; Tochio H; Ohnishi H; Kubota K; Kato Z; Shirakawa M; Kondo N
Mol Immunol; 2014 Mar; 58(1):66-76. PubMed ID: 24316379
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of myeloid differentiation factor 88(MyD88) by ST2825 provides neuroprotection after experimental traumatic brain injury in mice.
Zhang HS; Li H; Zhang DD; Yan HY; Zhang ZH; Zhou CH; Ye ZN; Chen Q; Jiang TW; Liu JP; Hang CH
Brain Res; 2016 Jul; 1643():130-9. PubMed ID: 27155455
[TBL] [Abstract][Full Text] [Related]
40. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.
Suzuki N; Suzuki S; Duncan GS; Millar DG; Wada T; Mirtsos C; Takada H; Wakeham A; Itie A; Li S; Penninger JM; Wesche H; Ohashi PS; Mak TW; Yeh WC
Nature; 2002 Apr; 416(6882):750-6. PubMed ID: 11923871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
